EDGAR Filing Documents for 0001144204-15-055944

Form 8-K - Current report:

SEC Accession No. 0001144204-15-055944

Filing Date

2015-09-22

Accepted

2015-09-22 16:53:14

Documents

Period of Report

2015-09-21

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	v420696_8k.htm	8-K	39009
2	EXHIBIT 10.1	v420696_ex10-1.htm	EX-10.1	112292
3	EXHIBIT 10.2	v420696_ex10-2.htm	EX-10.2	110735
4	EXHIBIT 10.3	v420696_ex10-3.htm	EX-10.3	188661
5	GRAPHIC	tex99-3_logo.jpg	GRAPHIC	17937
	Complete submission text file	0001144204-15-055944.txt		476956

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 8-K | Act: 34 | File No.: 001-36288 | Film No.: 151119751
SIC: 2834 Pharmaceutical Preparations